Cargando…
Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements
Glioblastoma (GBM) is characterized by aggressive growth and high rates of recurrence. Despite the advancements in conventional therapies, the prognosis for GBM patients remains poor. Immunotherapy has recently emerged as a potential treatment option. The aim of this systematic review is to assess t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606063/ https://www.ncbi.nlm.nih.gov/pubmed/37894718 http://dx.doi.org/10.3390/ijms242015037 |